Navigation Links
Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib,Combination in Non-Small Cell Lung Cancer Presented at American,Association of Cancer Research Annual Meeting

imately 75-80% of NSCLCs," commented Jean Nichols, Ph.D., Executive Vice-President and Chief Scientific Officer at Gloucester.

"The preclinical synergy seen in this study provides a strong rationale for conducting clinical studies of the combination. If similar results are seen clinically, the potential exists to substantially increase the use of TKIs such as erlotinib in a broader population of lung cancer," she concluded.

About Non-Small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related deaths worldwide. There are over 1.2 million cases of lung cancers every year in the world, and 1.1 million people will die from their disease. Non-small cell lung cancer accounts for approximately 80% of lung cancer.

About Romidepsin

Romidepsin is a novel agent in a new class of anti-cancer drugs known as histone deacetylase inhibitors. The Company is conducting a pivotal phase II study of romidepsin for patients with cutaneous T-cell lymphoma (CTCL) and has initiated a pivotal phase II study for patients with peripheral T-cell lymphoma (PTCL). Romidepsin has received Orphan Drug Designation from the Food and Drug Administration (FDA) for the treatment of non-Hodgkin T-cell lymphomas, which includes CTCL and PTCL. In addition, the European Agency for the Evaluation of Medicinal Products (EMEA) has issued Orphan Drug status for the treatment of both CTCL and PTCL. Fast Track status for CTCL has also been designated by the FDA. Romidepsin is in clinical trials for a variety of other hematological malignancies and solid tumors, including hormone refractory prostate cancer, pancreatic cancer and multiple myeloma. These trials and others are being conducted by the Company or the National Cancer Institute (NCI) under a Cooperative Research and Development Agreement (CRADA) with the Company.

About Gloucester Pharmaceuticals, Inc.

Gloucester Pharmaceuticals, Inc. is a privately-held, venture-backed company that develops an
'"/>




Page: 1 2 3

Related medicine technology :

1. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting
2. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
3. Gloucester Pharmaceuticals Announces Multiple Presentations of Preclinical Romidepsin Data at American Association of Cancer Research Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

Post Your Comments:
(Date:12/1/2009)..., ALBUQUERQUE, N.M., Dec. 1 Exa...oratory that discovers, develops and markets propr...ent of Scott Glenn as chairman of the company,s bo..., Prior to joining Exagen, Glenn was managing part... number of successful biomedical companies includi...
(Date:12/1/2009)... , BRIDGEWATER, N.J., Dec. 1 T...Biotech Products, L.P., announced today that it is...issues affecting women and people of color living ...cluding local educational events, media outreach a...mpany is sharing learnings from the GRACE study, t...
(Date:12/1/2009)... , NEW YORK, Dec. 1 ... changing market dynamics for an industry experien...thcare reforms are likely to drive up the effecti...nces industry, according to a report released tod...: Taxing times ahead - Which path will you take? ...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 3Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 4Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 5Apple Vending is a Strong Growth Segment Despite Tough Economic Times 59884 1Apple Vending is a Strong Growth Segment Despite Tough Economic Times 59884 2Apple Vending is a Strong Growth Segment Despite Tough Economic Times 59884 3McDivitt Law Firm 26apos 3Bs Treat Is No Trick Free Rides on Halloween in Colorado Springs 59881 1McDivitt Law Firm 26apos 3Bs Treat Is No Trick Free Rides on Halloween in Colorado Springs 59881 2McDivitt Law Firm 26apos 3Bs Treat Is No Trick Free Rides on Halloween in Colorado Springs 59881 3Aprima 2009 First Electronic Health Record and Practice Management System to Announce Support for Microsoft Windows 7 59878 1Aprima 2009 First Electronic Health Record and Practice Management System to Announce Support for Microsoft Windows 7 59878 2
...pril 4, 2007 -- CytImmune, a,clinical stage nanom...mercialization of multifunctional, tumor-targeted ...stract at the 43rd American,Society of Clinical On...5. The poster session will take place from 8:00 am...of CytImmune will,present the poster abstract enti...
... Journal of Cell Science Shows ONCONASE Uptake in,... April 05, 2007 /PRNewswire-FirstCall/ --,Alfacell...hers have,identified the pathway that ONCONASE (ra...he Journal of Cell Science (2007; 120: 1405-1411),...ity of Girona in,Spain and the University of Montp...
Other Medicine Technology:CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 3
(Date:12/1/2009)...en in Central and South America, study finds , ... 50 percent of intensive care unit patients worldw...f dying in the hospital, a new study finds. , R... (May 8, 2007) on 13,796 patients, aged 18 and old... 51 percent of patients were classified as infecte...
(Date:12/1/2009)...ecember 1, 2009)The Clinical Research Building (CR...dicine, has been honored for its sustainability co...ation, established by the U.S. Green Building Coun...on Institute (GBCI). LEED is the nation,s preemine...ion of green buildings., "Having a LEED certified...
(Date:12/1/2009)...GH VALLEY, Pa., Dec. 1 A...eted the previously announced sale of the assets o... under the Airthane® and Versathane® tra... of global polyurethane chemicals producer COIM Sp...anufacturing facility in Paulsboro, N.J. Terms of ...
(Date:12/1/2009)...Patient Safety Authority Encourages Older Persons ... New Consumer Tips Based Upon Authority Data ,... -- Ninety percent of all vaccine preventable deat...s in nursing homes, according to highlighted studi...2009 December Patient Safety Advisory . ,, Acc...
(Date:12/1/2009)...ents in California are unable to successfully obta...ospitals despite recent state legislation intended... study. , Posing as low-income uninsured patient...than one-third of the hospitals they approached an...an those allowed under California law, according t...
Breaking Medicine News(10 mins):Health News:Half of ICU Patients Suffer From Infections 2Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5Health News:Hospital price transparancy laws in California fall short, study finds 2
...riWest donates ,Medal of Honor, books and DVDs to ... of over 100 local,school children and military di...gressional Medal of Honor Foundation will present ...e of 5,300,copies they donated to California schoo...
...ajor spine conference and exhibition draws special... globe., DENVER, May 20 C5 Medical Werks, a le...eserving, total disc replacement devices,announced...dedicated to the study and treatment,of disorders ...
...ut, it may not be for every patient, one expert sa... Men with advanced prostate cancer that hasn,t spr...apy as soon as the prostate has been removed, a ne...ho weren,t," study co-author Dr. Gregory P. Swanso...
...ASHVILLE, Tenn., May 20 Ambulatory Services of,Am...has invested $75,million in Ambulatory Services of...identified acquisitions and to enable its growth s...te-site health care services in partnership with p...
...ARADISE VALLEY, Ariz., May 20 Dr. Theresa Ramsey ...blic on Allergies: Testing,and Treatment Options. ...untry that is using a new non-invasive treatment f...at 6850 E. Main Street,in Scottsdale, on June 7, 2...
...USTIN, Texas, May 20 The Lance Armstrong Foundati...ounder and chairman,regarding Senator Ted Kennedy,... Senator Kennedy, a champion for healthcare and a,...e dignity and strength that have shaped his lifelo...
Other Medicine News:Health News:5,000 California Schools Receive Book About Sacrifice, Courage 2Health News:C5 Medical Werks Joins in Sponsoring SpineWeek 2008 in Geneva, Switzerland 2Health News:Radiation Improves Survival for Advanced Prostate Cancer 2Health News:Radiation Improves Survival for Advanced Prostate Cancer 3Health News:Ambulatory Services of America, Inc. Announces Investment by Lindsay Goldberg 2
Micro Wire Driver
SmartDriver
...stem is a full-function, electric powered system t...ange of surgical applications including Arthroscop... Orthopedic Trauma, Oral and Maxillofacial Surgery... Because it is a complete, standardized and specia...
...nsists of a pistol-grip handpiece available in Pne...nge of couplers that can be used in a variety of o...artDriver XT offers significantly increased torque...river. The Battery SmartDriver XT accepts the full...
Medicine Products: